These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21377772)

  • 1. Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.
    Mravljak J; Monasson O; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Eur J Med Chem; 2011 May; 46(5):1582-92. PubMed ID: 21377772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a β-ketophosphonate structure.
    Auberger N; Frlan R; Al-Dabbagh B; Bouhss A; Crouvoisier M; Gravier-Pelletier C; Le Merrer Y
    Org Biomol Chem; 2011 Dec; 9(24):8301-12. PubMed ID: 22042341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial transferase MraY inhibitors: synthesis and biological evaluation.
    Lecerclé D; Clouet A; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Bioorg Med Chem; 2010 Jun; 18(12):4560-9. PubMed ID: 20537545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of gem-difluorinated nucleoside analogues of the liposidomycins and evaluation as MraY inhibitors.
    Xu XH; Trunkfield AE; Bugg TD; Qing FL
    Org Biomol Chem; 2008 Jan; 6(1):157-61. PubMed ID: 18075661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
    Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure.
    Dini C; Didier-Laurent S; Drochon N; Feteanu S; Guillot JC; Monti F; Uridat E; Zhang J; Aszodi J
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1209-13. PubMed ID: 11934590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
    Mihalyi A; Jamshidi S; Slikas J; Bugg TD
    Bioorg Med Chem; 2014 Sep; 22(17):4566-71. PubMed ID: 25127465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition.
    Fer MJ; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    J Org Chem; 2013 Oct; 78(20):10088-105. PubMed ID: 24044436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the chemistry of epoxy amides for the synthesis of the 2''-epi-diazepanone core of liposidomycins and caprazamycins.
    Sarabia F; Vivar-García C; García-Ruiz C; Martín-Ortiz L; Romero-Carrasco A
    J Org Chem; 2012 Feb; 77(3):1328-39. PubMed ID: 22283462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.
    Hotoda H; Furukawa M; Daigo M; Murayama K; Kaneko M; Muramatsu Y; Ishii MM; Miyakoshi S; Takatsu T; Inukai M; Kakuta M; Abe T; Harasaki T; Fukuoka T; Utsui Y; Ohya S
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2829-32. PubMed ID: 14611838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caprazamycins: Biosynthesis and structure activity relationship studies.
    Wiker F; Hauck N; Grond S; Gust B
    Int J Med Microbiol; 2019 Jul; 309(5):319-324. PubMed ID: 31138496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 2: role of the hydroxyl groups upon the inhibition of MraY.
    Dini C; Drochon N; Guillot JC; Mauvais P; Walter P; Aszodi J
    Bioorg Med Chem Lett; 2001 Feb; 11(4):533-6. PubMed ID: 11229764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of truncated bisubstrate inhibitors of aminoglycoside 6'-N-acetyltransferases.
    Gao F; Yan X; Shakya T; Baettig OM; Ait-Mohand-Brunet S; Berghuis AM; Wright GD; Auclair K
    J Med Chem; 2006 Aug; 49(17):5273-81. PubMed ID: 16913716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY.
    Dini C; Drochon N; Feteanu S; Guillot JC; Peixoto C; Aszodi J
    Bioorg Med Chem Lett; 2001 Feb; 11(4):529-31. PubMed ID: 11229763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and glycosidase inhibitory profiles of functionalised morpholines and oxazepanes.
    Burland PA; Osborn HM; Turkson A
    Bioorg Med Chem; 2011 Sep; 19(18):5679-92. PubMed ID: 21862336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
    Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
    Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
    Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
    J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling.
    Fer MJ; Bouhss A; Patrão M; Le Corre L; Pietrancosta N; Amoroso A; Joris B; Mengin-Lecreulx D; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2015 Jul; 13(26):7193-222. PubMed ID: 26008868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase.
    Branstrom AA; Midha S; Longley CB; Han K; Baizman ER; Axelrod HR
    Anal Biochem; 2000 May; 280(2):315-9. PubMed ID: 10790316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors.
    Oliver M; Le Corre L; Poinsot M; Corio A; Madegard L; Bosco M; Amoroso A; Joris B; Auger R; Touzé T; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2021 Jul; 19(26):5844-5866. PubMed ID: 34115086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.